Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-25 @ 5:17 PM
Study NCT ID:
NCT06107803
Status:
COMPLETED
Last Update Posted:
2025-03-26
First Post:
2023-10-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia
Sponsor:
Minerva Neurosciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-12
Completion Date Type:
ACTUAL
First Submit Date:
2023-10-13
First Submit QC Date:
None
Study First Post Date:
2023-10-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-13
Results First Submit QC Date:
None
Results First Post Date:
2025-03-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-06
Last Update Post Date:
2025-03-26
Last Update Post Date Type:
ACTUAL